SKI Market

A+| A| A-|

Indian Indices

Sensex

76,264.33 736.38
( 0.97%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

69,318.21 3,298.17
(5.00%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ICICI Bank Ltd

Industry : Banks - Private Sector

BSE Code

ISIN Demat

Book Value()

532174

INE090A01021

461.4525425

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ICICIBANK

19.17

961297.77

EPS(TTM)

Face Value()

Div & Yield %

69.92

0.89

Back

Astrazeneca Pharma India standalone net profit rises 5.64% in the December 2025 quarter

Feb 12,2026

Net profit of Astrazeneca Pharma India rose 5.64% to Rs 32.59 crore in the quarter ended December 2025 as against Rs 30.85 crore during the previous quarter ended December 2024. Sales rose 38.90% to Rs 611.57 crore in the quarter ended December 2025 as against Rs 440.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	611.57	440.29	39
OPM %	7.33	17.49	-
PBDT	48.90	84.64	-42
PBT	45.06	75.57	-40
NP	32.59	30.85	6

76,264.33 736.38 ( 0.97%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

69,318.21 3,298.17 (5.00%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)